Illness and drug modifiable factors associated with violent behavior in homeless people with severe mental illness: results from the French Housing First (FHF) program.


Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
02 03 2019
Historique:
received: 20 08 2018
revised: 31 10 2018
accepted: 05 11 2018
pubmed: 14 11 2018
medline: 23 4 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

The aim of this study was to investigate the factors associated with violent behavior in a large multicenter sample of Homeless Schizophrenia (SZ) and Bipolar Disorder (BD) (HSB) subjects. This multicenter study was conducted in 4 French cities: Lille, Marseille, Paris and Toulouse. Violent behavior was defined by at least one episode of verbal or physical violence in the last 6 months. Overall, 675 HSB patients, mean aged 38 years and 82.5% men were included, 458 SZ (68.4%) and 212 BD (31.6%). During the 6 months before evaluation, 213 (34.3%) committed at least one physical or verbal violence. In multivariate analysis, violence has been associated with younger age (aOR = 0.96[0.94-0.99], p = .001), number of nights in the street (aOR = 1.01[1.01-1.01]), BD diagnosis (aOR = 1.63[1.01-2.65], p = .04), higher current illness severity (CGI score) (aOR = 1.32[1.07-1.64], p = .01), higher rates of current manic episode (aOR = 2.24[1.32-3.81], p = .002), current alcohol use disorder (aOR = 2.05 [1.33-3.15], p = .001), antisocial personality disorder (aOR = 2.51[1.55-4.07], p < .001) and with antidepressant consumption (aOR = 2.01[1.01-4.04], p = .04). No specific antipsychotic or mood stabilizer has been associated with decreased rates of violent behavior, however clozapine, lithium and carbamazepine remained poorly prescribed. In case of violent behavior in HSB subjects, clinicians should focus in priority on the treatment of mania, antidepressant iatrogenic effect and alcohol use disorder by pharmacological and non-pharmacological treatments. Clozapine, lithium and carbamazepine should be chosen as the treatments of reference in this population but may be hard to manage in some cases. The current clinical trial number is NCT01570712.

Identifiants

pubmed: 30423419
pii: S0278-5846(18)30673-0
doi: 10.1016/j.pnpbp.2018.11.006
pii:
doi:

Substances chimiques

Psychotropic Drugs 0

Banques de données

ClinicalTrials.gov
['NCT01570712']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-96

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

G Fond (G)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France. Electronic address: guillaume.fond@ap-hm.fr.

L Boyer (L)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France.

M Boucekine (M)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France; Service Epidémiologie et Economie de la Santé, Assistance Publique Hôpitaux de Marseille, Marseille, France.

V Girard (V)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France; Department of Psychiatry, Sainte-Marguerite University Hospital, Marseille, France.

S Loubière (S)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France; Service Epidémiologie et Economie de la Santé, Assistance Publique Hôpitaux de Marseille, Marseille, France.

C Lenoir (C)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France; Department of Psychiatry, Sainte-Marguerite University Hospital, Marseille, France.

P Auquier (P)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France.

A Tinland (A)

School of Medicine - La Timone Medical Campus, CEReSS - Health Service Research and Quality of Life Center, Aix Marseille University, Marseille 3279, France; Department of Psychiatry, Sainte-Marguerite University Hospital, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH